Ahmed Glaucoma Valve: What It Is & How It Works

The Ahmed Glaucoma Valve is a small implantable device that drains excess fluid from inside the eye to lower dangerously high eye pressure. Unlike most other glaucoma drainage implants, it contains a built-in valve mechanism designed to regulate flow and prevent the pressure from dropping too low after surgery. It is one of the most widely used glaucoma drainage devices in the world, and its role has expanded over the decades from a last-resort option to a mainstream surgical choice for several types of hard-to-treat glaucoma.

What the Device Looks Like and How It Drains Fluid

The Ahmed Glaucoma Valve has two main parts: a thin silicone tube and a flat plate (sometimes called the body or reservoir). The tube is inserted into the front chamber of the eye, where fluid naturally circulates. The plate sits underneath the conjunctiva, the thin membrane covering the white of the eye, and is sutured to the outer wall of the eyeball. Fluid flows from inside the eye through the tube, into the plate’s chamber, and then gets absorbed by the surrounding tissue.

What sets the Ahmed apart from other drainage implants is its flow-restricting valve. The valve consists of two thin silicone membranes that form a chamber shaped like a funnel, wider at the inlet than the outlet. These membranes are pretensioned to open when eye pressure reaches about 8 to 12 mmHg and to close again once pressure drops back to a safe level.¹ The funnel shape creates a pressure difference that keeps the valve open even when the gap between the pressure inside and outside the eye is small, allowing fluid to move out steadily without a sudden rush. When pressure normalizes, the tension in the silicone membranes closes the valve, which is meant to prevent hypotony, a condition where eye pressure falls dangerously low.

Before the surgeon places the tube into the eye, the device is primed by flushing balanced salt solution through it with a syringe and cannula to confirm the valve opens and fluid flows properly.² This step matters because a valve that does not open reliably would leave the patient with uncontrolled pressure after surgery.

Silicone Versus Polypropylene Models

The Ahmed Glaucoma Valve has been manufactured in different materials over the years. The two most studied versions are the polypropylene model (S2) and the silicone model (FP7). Head-to-head comparisons found that the silicone FP7 delivered better pressure reduction, higher success rates, and fewer complications than the older polypropylene version.³ The plate material appears to influence how the body’s tissue responds to the implant, affecting how much scarring develops around it. Since scarring around the plate is ultimately what limits the device’s long-term performance, the shift toward silicone models was a meaningful upgrade. Today the FP7 is the most commonly implanted version for adults, with smaller models available for children.

Who Gets an Ahmed Valve

The device is primarily used for glaucoma that has not responded to eye drops, laser treatment, or conventional filtering surgery. The specific diagnoses vary, but neovascular glaucoma, which develops when abnormal blood vessels block the eye’s natural drainage, is consistently one of the most common reasons for implantation. In one large series, neovascular glaucoma accounted for roughly 45% of cases, followed by primary open-angle glaucoma at about 24% and congenital glaucoma at around 14%.⁴

A long-term review from a tertiary hospital in Spain confirmed that certain subtypes respond particularly well. Eyes with uveitic glaucoma (caused by inflammation inside the eye) or neovascular glaucoma tended to have higher starting pressures but actually showed better responses to the Ahmed valve than eyes with straightforward refractory open-angle glaucoma.⁵ That may seem counterintuitive, but it likely reflects the fact that these aggressive forms of glaucoma often have higher pressures to begin with, giving the device more room to make a measurable difference.

How the Ahmed Compares to Other Surgical Options

The two drainage implants most often studied side by side are the Ahmed valve and the Baerveldt implant. The Baerveldt has no built-in valve, which means the surgeon must temporarily block the tube with a suture during healing to prevent early over-drainage. The Ahmed’s valve lets it start lowering pressure right away, so patients typically see lower pressures and need fewer eye drops in the first days and weeks after surgery.⁶

Over the long haul, however, the Baerveldt tends to pull ahead. A major multicenter trial found that at three years, the Baerveldt group had a lower failure rate (about 34%) compared to the Ahmed group (about 51%), and the Baerveldt group needed fewer medications to maintain adequate pressure control.⁷ The actual pressure readings at three years were similar between the two devices, but the Ahmed patients required more supplemental eye drops to get there. So the trade-off is essentially this: the Ahmed provides quicker early control and lower short-term risk, while the Baerveldt may deliver better long-term results at the cost of a more complex early recovery.

The other major comparison is against trabeculectomy, the traditional filtering surgery where the surgeon creates a small flap in the eye wall to let fluid drain. The landmark Tube Versus Trabeculectomy (TVT) study, which included patients who had already had cataract or failed filtering surgery, found that both procedures achieved similar pressure reduction and medication use at five years. However, patients who had trabeculectomy were more likely to need additional glaucoma surgery down the line.⁸ When both procedures are combined with cataract surgery in the same sitting, trabeculectomy may achieve slightly higher overall success rates, but the tube group tends to have comparable final pressure levels.⁹

The Hypertensive Phase

One quirk of the Ahmed Glaucoma Valve that catches many patients off guard is the “hypertensive phase,” a temporary spike in eye pressure that typically occurs within the first one to six months after surgery. The body forms a fibrous capsule around the plate as part of normal wound healing, and during the early weeks of that process the capsule can become thick and tight enough to impede fluid absorption, driving pressure back up. In studies without any preventive treatment, roughly half of patients experience this spike.¹⁰

The hypertensive phase is usually managed with glaucoma medications temporarily, and in most cases the pressure settles as the capsule matures and becomes more porous. Researchers have tested several strategies to reduce how often the spike occurs. Injecting a steroid (triamcinolone) around the implant at the time of surgery cut the rate of the hypertensive phase roughly in half and delayed its onset from a mean of about 20 days to about 90 days.¹⁰ A more recent study found that injecting a small bubble of air into the front chamber of the eye during surgery reduced the rate of the hypertensive phase from about 49% to 19%.¹¹

What Happens Inside the Capsule

The fibrous bleb that forms around the Ahmed plate is not just scar tissue — it is the structure that ultimately absorbs the drained fluid. When researchers examined these capsules under the microscope, they found a two-layered architecture. The inner layer, which faces the plate, is made of compressed collagen fibers showing signs of degeneration, with cells that have transformed from ordinary fibroblasts into contractile myofibroblasts. The outer layer is highly vascularized, rich with tiny blood vessels.¹² Interestingly, researchers found blood clots (thrombosis) in the vessels of some capsules, and inflammatory cells were almost entirely absent.¹² This matters because it suggests the capsule’s thickening is driven more by tissue remodeling and blood vessel changes than by active inflammation, which has implications for how doctors try to manage it.

A comparative study of capsules from Ahmed valves and from trabeculectomies found no meaningful histological difference between the two — the same inner fibrodegenerative layer and outer fibrovascular layer in both.¹³ In other words, the body’s response to any surgical opening designed to drain eye fluid looks roughly the same, regardless of whether a tube implant or a simple flap is used.

Complications to Watch For

No eye surgery is complication-free, and the Ahmed valve carries its own specific risks. The most significant early complication is hypotony, excessively low eye pressure. Even though the valve is designed to prevent this, it does not always succeed. One study found that shallow anterior chambers (the space behind the cornea collapsing because pressure is too low) occurred in about 7% of Ahmed implantations. Hypotony and fluid buildup behind the retina (choroidal detachment) were far more common in those patients than in matched controls.¹⁴ In severe cases, hypotony may require a second procedure to temporarily block the tube from the inside until the eye stabilizes. One case report described using a polypropylene suture threaded into the tube lumen to occlude it when a patient developed pressure below 5 mmHg with corneal folds and choroidal effusion, which improved pressure to 10 mmHg after the revision.¹⁵

Over the longer term, tube erosion is a concern. The tube sits under the conjunctiva, and over months to years, the tissue covering it can thin and break down, leaving the tube exposed. Risk factors include prior eye surgeries (especially trabeculectomy), neovascular glaucoma, younger age, and excessive conjunctival scarring. The exact mechanism seems to involve both mechanical stress on the tissue and immune-mediated inflammation at the surgical site.¹⁶ In rare cases, the tube can erode through the cornea itself if there is long-standing contact between the tube tip and the inner corneal surface.¹⁷

Another gradual concern is loss of corneal endothelial cells, the single-layer lining on the back of the cornea that keeps it clear. The tube tip sits in the front chamber near the cornea, and over time its presence can accelerate the natural decline in these cells. One study measured the loss at about 12% per year after Ahmed implantation. A simple follow-up procedure to trim the tube shorter reduced that rate to about 3.5% per year.¹⁸ This is worth knowing because corneal endothelial cells do not regenerate — once enough are lost, the cornea swells and becomes cloudy.

The Ahmed Valve in Children

Pediatric glaucoma is rare but particularly challenging because children’s eyes are still growing, and many standard glaucoma surgeries do not hold up well in young tissue. The Ahmed valve has become one of the more commonly used devices in this population. A review of the evidence found that adequate pressure control can be achieved and can last five or more years, though most children will eventually need supplemental eye drops.¹⁹

Children face some complications that adults rarely do. As the eye grows, the tube can retract out of position, especially in infants. Pupillary irregularities and cataract formation are also more common in children, particularly in the first year of life.¹⁹ One study of pediatric Ahmed implantations reported that the most common complication was tube-cornea contact, which occurred in about 18.5% of eyes, and that over half of children required additional glaucoma medications after surgery.²⁰ When tubes do retract, a tube extender device can sometimes salvage the implant rather than requiring full replacement, though long-term success with extenders is achieved in roughly a third of cases.²¹

Pars Plana Placement for Complex Cases

In the standard procedure, the Ahmed tube enters the eye through the front, near the edge of the cornea. But some patients have anatomy or disease that makes this approach impractical — for example, eyes that have had the vitreous gel removed (vitrectomized eyes) or eyes with severe disease in the back of the eye. In these cases, surgeons can place the tube through the pars plana, a zone a few millimeters behind the corneal edge that leads directly to the back chamber of the eye. The Ahmed valve has specific models (PC7 and PC8) designed for this approach.²²

This technique has been studied in combination with vitrectomy for patients with neovascular glaucoma and steroid-induced glaucoma. In one series, eyes with neovascular glaucoma saw their pressure drop from nearly 38 mmHg to about 14 mmHg, and eyes with steroid-induced glaucoma dropped from about 28 mmHg to about 14 mmHg, with visual acuity improving in both groups.²³ A separate study confirmed that pars plana placement significantly reduced both eye pressure and the number of medications needed, with results holding through the follow-up period.²⁴

Do Anti-Scarring Drugs Help

Because the bleb’s fibrous capsule is the main long-term bottleneck for drainage, researchers have tried pairing the Ahmed valve with agents that slow scarring. Mitomycin C, a drug commonly used during trabeculectomy to inhibit tissue growth, has been tested alongside tube implants with mixed results. A systematic review found that out of four studies evaluating mitomycin C with tube surgery, only one showed a significant benefit in pressure reduction at 12 months. The others found no meaningful difference, with one concluding that mitomycin C only helped during the initial wound healing period.²⁵ Anti-VEGF agents like bevacizumab were also evaluated, and two out of five studies reported significant differences favoring bevacizumab use at 12 months.²⁵ The upshot is that neither adjunct has proven reliably beneficial with tube implants the way mitomycin C has for trabeculectomies, and current practice varies widely among surgeons.

Monitoring the Implant After Surgery

Follow-up after Ahmed valve surgery involves regular pressure checks, medication adjustments, and imaging to make sure the tube is positioned correctly and the tissue around it looks healthy. One challenge arises in patients whose corneas are cloudy, which can make it impossible to see the tube through the usual lens-based examination. In these cases, anterior segment optical coherence tomography (a non-contact imaging technique that produces cross-sectional pictures of the front of the eye) can visualize the tube’s position, its passage through the eye wall, and whether the opening is patent, even when a direct view is blocked.²⁶

High-magnification OCT imaging can also evaluate the tightness of the fit where the tube passes through the sclera, which matters because a loose fit could allow fluid to leak alongside the tube rather than through it. This kind of detailed assessment is useful both early after surgery (to confirm a good seal) and months to years later (to catch subtle erosion or migration).²⁷ For most patients, these imaging techniques remain a specialist tool rather than a routine part of every visit, but they have become increasingly important for troubleshooting when pressure control is unexpectedly poor or when complications are suspected.

1
PubMed Central. Ahmed glaucoma valve implant: surgical technique and complications
2
PubMed Central. Functionality and Priming Stream Patterns of the Ahmed Glaucoma Valve in a Laboratory Setting
3
PubMed. Comparison of polypropylene and silicone Ahmed Glaucoma Valves
4
PubMed Central. Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications
5
PubMed. Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
6
PubMed. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome
7
PubMed Central. Three-year treatment outcomes in the Ahmed Baerveldt comparison study
8
50 Studies Every Ophthalmologist Should Know. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior Ocular Surgery and Uncontrolled Glaucoma
9
PubMed Central. Comparative outcomes of phaco-trabeculectomy versus phaco-tube implantation: a 6-year review
10
PubMed Central. Hypertensive phase and early complications after Ahmed glaucoma valve implantation with intraoperative subtenon triamcinolone acetonide
11
PubMed Central. Effect of intracameral air injection during Ahmed glaucoma valve implantation on hypertensive phase
12
PubMed Central. Histopathologic Findings in Early Encapsulated Blebs of Young Patients Treated With the Ahmed Glaucoma Valve
13
PubMed Central. Comparative Study of Encapsulated Blebs Following Ahmed Glaucoma Valve Implantation and Trabeculectomy with Mitomycin-C
14
PubMed Central. Effect of immediate shallow anterior chamber after Ahmed glaucoma valve implantation on intermediate-term intraocular pressure control
15
PubMed Central. Ab Interno Occlusion of Ahmed Glaucoma Valve Tube with a 4-0 Polypropylene Suture in a Patient with Hypotony
16
Scientific Reports. Tube erosions following glaucoma drainage device implantations
17
PubMed Central. Transcorneal tube erosion of an ahmed valve implant in an adult
18
PubMed. Effect of Postoperative Trimming of the Tube Portion of Ahmed Glaucoma Valve on Corneal Endothelial Cell Loss
19
PubMed Central. Ahmed glaucoma valve in children: A review
20
American Journal of Ophthalmology. The Ahmed Valve in refractory pediatric glaucoma
21
Journal of Glaucoma. Ahmed Valve Tube Extension in Pediatric Glaucoma
22
Saudi Journal of Ophthalmology. Vitrectomy combined with posterior-segment Ahmed valve implant: A case series study
23
Retina. Pars Plana Ahmed Valve and Vitrectomy in Patients with Glaucoma Associated with Posterior Segment Disease
24
PubMed Central. Pars Plana Ahmed Valve Implantation for Vitrectomized Eyes With Refractory Glaucoma
25
PubMed Central. The efficacy of adjunctive mitomycin C and/or anti-VEGF agents on glaucoma tube shunt drainage device surgeries: a systematic review
26
PubMed. Glaucoma tube imaging using anterior segment optical coherence tomography in patients with opaque cornea
27
PubMed. Evaluation of the tightness of contact between limbal sclera tunnel and tube following Ahmed glaucoma valve implantation